This site is intended for UK healthcare professionals only and contains promotional information.UK Flag Please visit the MHRA Yellowcard site to report an Adverse Event.

Prescribing Information can be found under Featured Medicines

Therapy Areas

View All

Diabetes and Endocrinology

Menarini becomes exclusive distributor for INVOKANA® (canagliflozin) and VOKANAMET® (fixed-dose combination of canagliflozin and metformin) in the UK. Learn more about the treatment for Type 2 Diabetes

Anti-infectives

Learn more about our Anti-infective portfolio, and the work we do to support the fight against Antimicrobial Resistance (AMR).

Cardiology

Learn more about our Cardiology portfolio and the work we do to support ongoing clinical education and service redesign.
Learn more about A. Menarini Farmaceutica Internazionale SRL

Learn more about A. Menarini Farmaceutica Internazionale SRL

We launched in the UK in 1999 with a passion for improving patient outcomes. We've come a long way but there's always more to be done. Click below to learn more about us.

PP-MN-UK-0582 November 2024

Adverse events should be reported. Reporting forms and information can be found at www.yellowcard.mhra.gov.uk or search for MHRA Yellow Card in Google Play or Apple App Store.

Adverse events should also be reported to A. Menarini Farmaceutica Internazionale SRL.

Phone 0800 085 8678